THE AUSTRALIAN: “When was the last time the epidemiologists treated a 48-year-old man dying of prostate cancer, surrounded by a young family?” asks David Malouf, president of the Urological Society of Australia and New Zealand: “We are not talking about statistics, we are talking about human beings.” READ MORE>
In a testy debate in Australia, he was replying to critics of the society’s recent decision to follow the American Urological Association recommendation that men over 40 be offered PSA tests.
Advertisements
Leave a Reply